The Immune System – News and Features

Sainsbury Laboratory scientists will lead an €11.8-million research consortium that will study the potential uses for RNA interference in treating disease.

BioTrove’s high-throughput technology will enable the researchers to investigate human cellular response to chemical weapons and adult stem cell differentiation.

CombinatoRx shows data from its first biologic/small molecule High Throughput Screening effort identifying drug classes that synergistically enhance the activity of the oncology-relevant cytokine TNF-related apoptosis.

Researchers supported by the National Institute of Dental and Craniofacial Research have developed a device that measures proteins in saliva to indicate a developing disease in the mouth or body.

Nastech to evaluate Carrington's GelSite for potential to enhance intranasal delivery of Nastech's peptide and protein therapeutics in liquid formulations.

The option will provide the Novosom with a worldwide licence to antisense inhibitors targeting the CD40 membrane protein for all indications.

Agilent signs a definitive agreement to acquire life science research reagents and instruments provider company Stratagene.

Virginia Commonwealth University researchers have sequenced the genome of a bacteria found in the human mouth that can cause dangerous infections.

A research has shown that the application of a mass spectrometry technique to glyconconjugates could lead to understand biological structures and their activity.

USPT has confirmed all the claims in PharmaStem’s patents regarding umbilical cord blood stem cells.